Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
NASDAQ Global Market · Equity
$28.96
+$0.13 · +0.45%
· Aug 21, 4:00 PM ET
$28.96
Previous close+$0.13 · +0.45%
· Aug 21, 4:00 PM ET
$29.01
+$0.18 · +0.62%
Regular session · ET · Market data may be delayed.
The Macquarie Focused International Core ETF (EXUS) is a passively managed exchange-traded fund that tracks the MSCI World ex USA Index, providing diversified exposure to large- and mid-cap stocks outside the United States. The fund’s portfolio is heavily weighted toward the finance sector (approximately 26%) and health technology (about 10%), with the majority of assets located in Europe (59%), followed by Asia (22%) and North America (11%). Top holdings include SAP SE and ASML Holding NV. EXUS has seen strong asset growth, with assets under management reaching $2.93 billion and a one-year price performance increase of 15.64%. The ETF does not pay dividends and has a low expense ratio of 0.15%. Shares are issued by Deutsche Bank AG under the Xtrackers brand, and the fund was launched on March 6, 2024.
Fund assets
16.95M USD
Expense ratio
0.59%
NAV
$28.75
Average volume
15.89K
Volume
2.27K
Day range
$28.93 – $29.044
52-week range
$23.315 – $30.00
Previous close
$28.83
Price change
1 day
+0.45%
1 month
+4.21%
3 months
+6.39%
Year to date
+11.38%
1 year
+12.42%
3 years
+16.12%
5 years
+16.12%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 23, 2026.
Portfolio composition
Fund income
Dec 24, 2025
Irregular
Dec 24, 2025
Dec 31, 2025
$0.009
Latest coverage
No ETF news is currently available.
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
